EntityQ113861520· pop 7· linked from 1 articlesOlajumoke AkinjideSign in to saveNigerian politicianRecent publications · Crossref5 total works indexedTocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial · 2021 · cited 1,518xConvalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial · 2021 · cited 411xCasirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial · 2022 · cited 285xBaricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis · 2022 · cited 252xAMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders · 2019 · cited 227xvia Crossref · CC0Wikidata factsImageOlajumoke Akinjide.PNGvia Wikidata · CC0Available in 6 languagesHausaIgbokaiKanuriYorubavia Wikidata sitelinks · CC0ConnectionsUnited StatesCountrypolitical partyEntityCategories1959 births21st-century Nigerian politicians21st-century Nigerian women politiciansAlumni of King's College LondonHarvard Law School alumniLiving peoplePeople from Oyo State